Early Heparin Administration Reduces Risk for Left Atrial Thrombus Formation during Atrial Fibrillation Ablation Procedures

Stefan Asbach, Jürgen Biermann, Christoph Bode, Thomas S Faber, Stefan Asbach, Jürgen Biermann, Christoph Bode, Thomas S Faber

Abstract

Objective. Despite the use of anticoagulation during left atrial (LA) ablation procedures, ischemic cerebrovascular accidents (CVAs) are recognized as a serious complication. Heparin is usually given after safe transseptal access has been obtained, resulting in a short unprotected dwell time of catheters within the LA, which may account for CVAs. We investigated the frequency of CVAs and LA thrombus formation as detected by intracardiac ultrasound (ICE) depending on the timing of heparin administration. Methods and Results. Sixty LA ablation procedures with the use of ICE were performed in 55 patients. Patients were grouped by heparin administration after (Group I, n = 13) and before (Group II, n = 47) transseptal access. Group I patients were younger (56.6 ± 13.7 versus 65.9 ± 9.9 years, P = .01); other clinical and echocardiographic characteristics did not differ between groups. Early thrombus formation was observed in 2 (15.4%) of group I patients as compared to 0% of group II patients (P = .04). One CVA (2.1%) occurred in one group II patient without prior thrombus detection, and none occurred in group I patients (P = ns). Conclusion. Early administration of heparin reduces the risk of early intracardiac thrombus formation during LA ablation procedures. This did not result in reduced rate of CVAs.

Figures

Figure 1
Figure 1
The circular mapping catheter can clearly be visualized in the antrum of the left superior pulmonary vein. Attached to the inferior part of the ring of electrodes, a mobile thrombus can clearly be seen (encircled). Immediately measured ACT was 289 s.
Figure 2
Figure 2
A mobile thrombus (encircled) is attached to the tip of the transseptal sheath before the advancement of a catheter and before heparin administration.
Figure 3
Figure 3
Histogram showing incidence of left atrial (LA) thrombi, cerebrovascular accidents (CVA), and the combined event rate. LA thrombi occurred more frequently in group I patients (P = .04).

References

    1. Haïssaguerre M, Jaïs P, Shah D, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. New England Journal of Medicine. 1998;339(10):659–666.
    1. Calkins H, Reynolds MR, Spector P, et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. Circulation Arrhythmia and Electrophysiology. 2009;2(4):349–361.
    1. Ellis ER, Culler SD, Simon AW, Reynolds MR. Trends in utilization and complications of catheter ablation for atrial fibrillation in Medicare beneficiaries. Heart Rhythm. 2009;6(9):1267–1273.
    1. Fisher JD, Spinelli MA, Mookherjee D, Krumerman AK, Palma EC. Atrial fibrillation ablation: reaching the mainstream. Pacing and Clinical Electrophysiology. 2006;29(5):523–537.
    1. Calkins H, Brugada J, Packer DL, et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace. 2007;9(6):335–379.
    1. Saliba W, Thomas J. Intracardiac echocardiography during catheter ablation of atrial fibrillation. Europace. 2008;10(3):iii42–iii47.
    1. Asbach S, Biermann J, Blanke P, Pache G, Bode C, Faber TS. Incidental finding of a pulmonary embolus by intracardiac echocardiography during an atrial fibrillation ablation procedure. Europace. 2010;12:1199–1200.
    1. Kalman JM, Olgin JE, Karch MR, Lesh MD. Use of intracardiac echocardiography in interventional electrophysiology. Pacing and Clinical Electrophysiology. 1997;20(9 I):2248–2262.
    1. Patel D, Bailey SM, Furlan AJ, et al. Long-term functional and neurocognitive recovery in patients who had an acute cerebrovascular event secondary to catheter ablation for atrial fibrillation. Journal of Cardiovascular Electrophysiology. 2010;21(4):412–417.
    1. Scherr D, Sharma K, Dalal D, et al. Incidence and predictors of periprocedural cerebrovascular accident in patients undergoing catheter ablation of atrial fibrillation. Journal of Cardiovascular Electrophysiology. 2009;20(12):1357–1363.
    1. Schrickel JW, Lickfett L, Lewalter T, et al. Incidence and predictors of silent cerebral embolism during pulmonary vein catheter ablation for atrial fibrillation. Europace. 2010;12(1):52–57.
    1. Röther J, Laufs U, Böhm M, et al. Consensus paper on peri-interventional and postinterventional stroke during cardiac catheter procedures. Nervenarzt. 2009;80(10):1205–1215.
    1. Ren JF, Marchlinski FE, Callans DJ. Left atrial thrombus associated with ablation for atrial fibrillation: identification with intracardiac echocardiography. Journal of the American College of Cardiology. 2004;43(10):1861–1867.
    1. Bruce CJ, Friedman PA, Narayan O, et al. Early heparinization decreases the incidence of left atrial thrombi detected by intracardiac echocardiography during radiofrequency ablation for atrial fibrillation. Journal of Interventional Cardiac Electrophysiology. 2008;22(3):211–219.
    1. Hussein AA, Martin DO, Saliba W, et al. Radiofrequency ablation of atrial fibrillation under therapeutic international normalized ratio: a safe and efficacious periprocedural anticoagulation strategy. Heart Rhythm. 2009;6(10):1425–1429.
    1. Wazni OM, Beheiry S, Fahmy T, et al. Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period. Circulation. 2007;116(22):2531–2534.
    1. Di Biase L, Burkhardt JD, Mohanty P, et al. Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio. Circulation. 2010;121(23):2550–2556.
    1. Latchamsetty R, Gautam S, Bhakta D, et al. Management and outcomes of cardiac tamponade during atrial fibrillation ablation in the presence of therapeutic anticoagulation with warfarin. Heart Rhythm. 2011;8(6):805–808.

Source: PubMed

3
S'abonner